Imkeldi 80 mg/mL oral solution Images
Generic Name: imatinib
This medication has been identified as Imkeldi 80 mg/mL oral solution and is used for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Dermatofibrosarcoma Protuberans, and Gastrointestinal Stromal Tumor. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.
Images of medication
Imkeldi
- Generic Name
- imatinib
- Strength
- 80 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shorla Oncology Inc.
- National Drug Code (NDC)
- 81927-0201
See also:
More about Imkeldi (imatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.